Introduction
Chemical carcinogenesis induced by lifestyle factors like cigarette smoking is a major research area in molecular epidemiology. Cigarette smoke is a well known source of chemical carcinogens and comprises a complex mixture of over 60 proven, probable and possible carcinogenic agents (1) . It is known to induce a series of biomarkers for genotoxic, pre-carcinogenic effects, both in target tissue as in surrogate target tissue like peripheral blood mononuclear cells (PBMC) (2, 3) . Many of these early effects, e.g. DNA adducts, micronuclei, chromosome aberrations and mutations, are detectable in blood cells long before health effects appear (4, 5) .
Gene expression profiling by DNA microarray technology is considered a promising tool to gain more knowledge on the effects of toxicant exposure on the transcriptome level (6) (7) (8) . The development of tools for analyzing differential gene expression of many genes simultaneously has provided the opportunity for analyzing effects in exposed populations at the genome level, thereby studying the biological response to environmental exposure in an integrative manner.
Differential gene expression in human peripheral blood cells in vivo has been reported in a few studies (9) (10) (11) (12) . In a study on human leukocyte gene expression in smokers versus non-smokers, particular gene expression modulations have been found to correlate significantly with plasma cotinine levels and these genes accurately distinguished smokers from non-smokers (10) . No study has yet associated gene expression in exposed populations with established biomarkers like DNA adducts, which would provide an important opportunity for phenotypical anchoring of gene expression profiles.
The goal of our study therefore, was to investigate which genes are differentially expressed in blood cells from smokers as compared to non-smokers and for which genes the changes in expression correlate with aromatic DNA adduct levels. In order to reduce the potential impact from differences in genetic background, monozygotic twin pairs that were discordant in their smoking behavior were investigated as study subjects, implying that each twin pair consisted of one smoker and one non-smoker. Plasma levels of cotinine (a stable metabolite of nicotine) levels were measured to confirm smoking behavior. We used a toxicologically focused cDNA microarray to analyze gene expression differences as we anticipate that potential biomarker genes for cigarette smoke exposure should be represented within such a typical selection of target genes.
Materials and methods

Study population and blood collection
Participants were registered members of the East-Flanders Prospective Twin Survey (EFPTS) (13) . All twins over age of 20 years were sent questionnaires to collect information on smoking behavior. Twin pairs were included if they reported to be monozygotic and discordant in cigarettesmoking behavior (per twin pair one individual is a smoker whereas the other is a non-smoker). Initially, the study population consisted of 10 pairs of smoking-discordant twins; 5 male-male pairs and 5 female-female pairs. Genotyping for several biotransformation and DNA repair genes indicated that the two individuals of one male-male twin pair differed in 6 out of 19 polymorphisms (data not shown) and thus appeared to be a dizygotic twin pair. This twin pair was therefore excluded from further analysis. Among the non-smokers, there were seven never smokers. Two were former smokers and quit smoking at least 13 months prior to the study. Subjects gave informed consent and the study was approved by the Local Committee of Medical Ethics of the Catholic University of Leuven, Belgium. Venous blood was collected into one tube containing ethylenediamine tetraacetic acid (EDTA) and into five PAXgene Blood RNA tubes (PreAnalytix, Qiagen, Hilden, Germany) for immediate stabilization of intracellular RNA. Tubes were kept at 4 C until DNA and RNA isolation. The PAXgene system was used as it provides a robust standardized and simple method to collect blood for gene expression purposes in the field, where timely isolation of, e.g. lymphocytes is not possible.
Total RNA isolation Total RNA was isolated within a week after blood collection according to the manufacturer's instructions with minor modifications using the PAXgene Blood RNA kit (PreAnalytix, Qiagen, Hilden, Germany). The entire procedure was carried out at room temperature. Samples that did not show a distinct RNA-debris phase separation were submitted to an extra centrifugation step. RNA purity was determined spectrophotometrically, based on A260/A280 ratios. RNA integrity was determined on the BioAnalyzer and RNA was regarded intact when showing two distinct bands for 28S and 18S RNA.
Gene expression analyses by cDNA microarrays A common reference RNA pool was made from aliquots of all individuals that yielded sufficient RNA. On all arrays, three RNA samples were hybridized together (14) , i.e. the common reference sample and samples from the two individuals of a twin pair: the smoker and the non-smoker (for hybridization design, see Table I ). This allowed for analyzing differential gene expression at the level of twin pairs, and also at group levels for nonsmokers and smokers. Total RNA was reverse transcribed and labeled for cDNA microarray analysis according to the TIGR protocol for amino-allyl labeling of total eukaryotic RNA for microarrays as described previously (15) . For each individual, three aliquots of total RNA were used and labeled with Cy5, Cy3 (Amersham Biosciences, Freiburg, Germany) or Alexa Fluor 594 (ARESÔ DNA labeling kit, Molecular Probes, Leiden, The Netherlands), according to the manufacturers' instructions. For each twin pair, three hybridizations were performed, using a design in which each sample was labeled by each dye once (see Table I ). Equal amounts of labeled cDNA were combined and hybridized to Phase1 Human Tox 600 cDNA microarrays (Phase-1 Molecular Toxicology, Santa Fe, NM, USA), which contains genes in quadruplicate, in toxicologically relevant categories such as apoptosis, cell cycle, proliferation, biotransformation and metabolism and inflammation.
Microarrays were scanned on a ScanArrayExpress scanner (Perkin Elmer, Boston, MA, USA) with a fixed laser power and a variable photomultiplier gain, such that no spots were saturated. TIFF images for the separate fluorophores were imported into Imagene (BioDiscovery, Marina del Rey, CA, USA) and translated into raw data files, which were transformed and analyzed using GeneSight (BioDiscovery). Local background was subtracted and low expression values (<5 pixel intensities) and bad spots were omitted. Thereafter, data were log 2 transformed and normalized with Locally Weighed Scatterplot Smoothing (LOWESS). After calculation of the differences, replicate spots were combined omitting outliers greater than two times the standard deviation, so that eventually the mean intensities were based on 12 replicates per spot (3 arrays · 4 replicates per array).
Gene expression analyses by real-time PCR Real-time PCR was performed to validate the microarray results for a selection of genes. cDNA was generated from 2 mg of total RNA according to the manufacturer's instructions using the Bio-Rad iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA). Aliquots were used for realtime PCR on the BioRad MyiQ iCycler Single Color real-time PCR detection system using iQÔ SYBR Ò Green Supermix, containing all ingredients; iTaq Polymerase, dNTPs, SYBR Green I and buffers. Reactions were initiated for 3 min at 95 C, then 40 cycles of 15 s at 95 C and 45 s at 60 C were run. Melting curve analysis was performed starting at 60 C with stepwise temperature elevations of 0.5 C every 10 s. Beta-actin (ACTB), cyclophillin A (PPIA) and beta-2-microglobulin (B2M) were included as reference genes (internal controls) and all reactions were performed in duplicate. No template controls (water controls) and a dilution series of a pool of all cDNA samples from the study were included to estimate PCR efficiency. Primer sequences used were as follows: OGG1:
0 (forward) and 5 0 -GCGCATGGCTTCATAAAGGA-3 0 (reverse); and SERPINB2: 5 0 -CGATTTTGCAGGCACAAGCT-3 0 (forward) and 5 0 -CC-TGTGGATGCATTGATTGC-3 0 (reverse).
Data analysis
Computational and statistical analyses of the microarray data were performed using software programs GeneSight (BioDiscovery) and SPSS 11.5 (SPSS Inc., Chicago, IL, USA). Gene expressions as modulated by cigarette smoking were identified using several approaches, either by analyzing twin pairs (the expression differences between a smoker and non-smoker directly) or by analyzing each person individually (the expression difference between an individual and the common reference) through pair-wise analyses.
Confidence analysis, performed in GeneSight at >99% confidence level and >0.1 regulation level, was used to find differentially expressed genes within the twin pairs. For testing differences between smokers and non-smokers, using the expression differences between each individual and the common reference, the non-parametric 2-related samples Wilcoxon test in SPSS 11.5 was used. Next to these two tests, the signal-to-noise ratio for the smokers versus the non-smokers was calculated: (mean difference smokers/reference À mean difference non-smokers/reference )/(stdev difference smokers/reference + stdev difference non-smokers/reference ). The combination of these approaches was used in order to limit the number of false-positives. In addition, Spearman correlation tests were performed to investigate significant correlations of individual gene expressions with individual aromatic DNA adduct levels. For the real-time PCR analyses, DC t values were calculated for each gene of interest (16) . Three different approaches for normalizing these data were used as follows: (i) b-actin was used as the housekeeping or 'stably expressed' gene, (ii) the average of three housekeeping or 'stably expressed' genes was used (beta-actin ACTB, beta-2-microglobulin B2M and cyclophilin A PPIA) or (iii) no housekeeping genes were used but the amount of input RNA for a reference and DC t values were calculated directly for the gene of interest by subtracting the common reference C t from the test sample C t .
Gene ontologies were retrieved from http://www.ncbi.nlm.nih.gov/ with LocusLink or Gene. Analysis of biologically enriched pathways was performed in the Expression Analysis Systematic Explorer (EASE, http:// david.niaid.nih.gov/ease) (17) .
Cotinine measurements Plasma was collected from EDTA blood by centrifugation. Plasma cotinine was measured by high performance liquid chromatography (HPLC) according to the protocol described by Van Vunakis et al. (18) with the exception of the presence of EDTA in the standard. The significance of the difference between smokers and non-smokers was analyzed with a Wilcoxon test for non-parametric analysis of 2-related samples in SPSS 11.5. DNA adduct measurements Leukocyte fractions were isolated from whole blood (after removal of the plasma layer) through erythrocyte lysis (lysis buffer containing 155 mM NH 4 Cl, 10 mM KHCO 3 , 10 mM EDTA:blood ¼ 3:1) for 30 min at 4 C. Leukocytes were stored at À80 C until DNA isolation. DNA was isolated by standard phenol extraction (19) . DNA adduct levels were measured by 32 P-postlabeling with Nuclease-P1 enrichment as originally described by Reddy and Randerath (20) with minor modifications as described by Godschalk et al. (19) . The significance of the difference between smokers and non-smokers was analyzed with a Wilcoxon non-parametric test for 2-related samples in SPSS 11.5.
Results
Differential gene expression in blood caused by cigarette smoking was studied in blood cells from monozygotic twins discordant in smoking behavior. The characteristics of the study population are shown in Table II. The average plasma cotinine level in non-smokers was significantly lower than in smokers, namely 5.6 ± 0.2 ng ml À1 versus 247.6 ± 54.7 ng ml À1 (mean ± SE, P ¼ 0.008). Average DNA adduct levels were 1.2 ± 0.2 adducts per 10 8 nucleotides in the non-smokers group; significantly different (P ¼ 0.04) from the average of 2.0 ± 0.2 adducts per 10 8 nucleotides in the smokers group.
For differential gene expression analysis, three RNA samples were hybridized on every cDNA microarray, namely of the smoker and non-smoker samples from the same twin pair and a common reference sample. Through a combination of several approaches, genes were identified with altered expression due to cigarette smoking. Either data of twin couples (the expression differences between a smoker and non-smoker) or data from each person individually (the expression difference between an individual and the common reference) were analyzed. Using the data of twin pairs, confidence analysis revealed 34 differentially expressed genes. Using the data from smoking and non-smoking individuals, 76 differentially expressed genes in smokers compared with non-smokers were revealed by a nonparametric Wilcoxon signed ranks test for 2-related samples. In addition, 44 genes showed a signal-to-noise ratio for the smokers versus the non-smokers of >0.5. The data of these tests are summarized in a VENN-diagram ( Figure 1 ). The seven genes in the intersection of the diagram were identified by all three tests and appeared upregulated in the smokers.
Second, genes that correlated with DNA adducts were identified by Spearman correlation tests. Seven genes that scored high on correlation coefficient are reported in Table III . For most genes, such as OGG1, gene expression changes appeared to be negatively correlated with DNA adduct levels.
For a selection of genes that might be most interesting for future molecular epidemiology studies based on significance and biological relevance, the expression differences were verified by means of real-time PCR. For the cigarette smoking-related effects, SOD2, PTEN, ATF4 and MAPK14 were selected. OGG1, IL10, APP, AXIN1, PCK2, BAK and CSF1R were selected based on correlations with DNA adduct levels. Furthermore, plasminogen activator inhibitor 2 (SERPINB2) was included based on significant differential expression in previous in vitro studies with PBMC. Cytochrome P450 1B1 (CYP1B1) was included as this gene is known to be affected by, e.g. PAHs found in cigarette smoke and to be upregulated in smokers (21) (22) (23) and it also responded strongly to exposure to cigarette smoke condensate in vitro (unpublished data). For SOD2, MAPK14 and ATF4, the microarray data were reproduced by real-time PCR, especially when applying the DC t method (Table IV) . For PTEN, real-time PCR results showed no significant difference between smokers and nonsmokers, in contrast to the microarray data. For SERPINB2 and CYP1B1, however, real-time PCR showed differential expression in smokers versus non-smokers (P-values 0.021 and 0.008, respectively), where microarray analysis did not report an effect. When real-time PCR gene expressions for OGG1, IL10, APP, AXIN1, PCK2, BAK and CSF1R were correlated with DNA adduct levels, the correlations found for the microarray data with DNA adducts could not be reproduced (data not shown). Ontologies of the reported genes are shown in Table V .
Discussion
In nine monozygotic twin pairs discordant for smoking, we investigated whether cigarette smoking causes differential gene expression of toxicologically relevant genes in peripheral blood cells and whether expression levels correlate with a biomarker for early effects, i.e. DNA adducts. By analyzing cigarette smoke-induced differential gene expression in monozygotic twins, we reduced the impact of interindividual variability due to variation in genetic background. It also provided the opportunity to perform pair-wise analyses, adding statistical power to the study. The analyses revealed several genes to be reproducibly differentially expressed due to cigarette smoking.
Genes which were differentially expressed in smokers compared to non-smokers were identified by a combination of several approaches, namely non-parametric Wilcoxon test for 2-related samples, confidence analysis and signal-to-noise calculation. We choose for this combination of different approaches as it is likely to reduce the number of false-positive calls. The genes that were found by all three approaches ( Figure 1 ) were considered the most discriminatively relevant genes. Resulting genes are activating transcription factor 4 (ATF4), mitogen-activated protein kinase 14 (MAPK14 aka p38), superoxide dismutase 2/Mn (SOD2), alpha 1-antitrypsin (SERPINA1), paxillin (PXN), myeloid cell differentiation protein-1 (MCL1) and phosphate and tensin homolog (PTEN). These genes were all upregulated in smokers as compared to non-smokers.
ATF4, SOD2 and MAPK14 were the genes differentially expressed by cigarette smoking, which were confirmed by real-time PCR. In addition to these genes, two other genes that did not show significance in the microarray results were included in the real-time PCR analyses, i.e. CYP1B1 and SERPINB2. In the real-time PCR analysis, CYP1B1 showed, for every twin pair, a higher expression in the smoker than in the non-smoker, which agrees with other studies (21) (22) (23) . However, microarray analysis did not demonstrate a significant effect for CYP1B1 due to the relatively high standard error of the mean, which is probably due to the low mRNA abundance of this gene in peripheral blood cells. Also, SERPINB2 showed significance in the real-time PCR analysis, which agrees with previous in vitro experiments on human lymphocytes treated with cigarette smoke condensate (24) . Upon microarray analysis, no significant effects No housekeeping genes were used but the amount of input RNA for normalization.
were observed for this gene, again possibly due to the low abundance of its mRNA. Based on the current data, the genes that we would propose to be suitable for biomonitoring in cigarette smokeexposed humans are ATF4, SOD2, MAPK14, CYP1B1 and SERPINB2 since they showed to be reproducibly differentially expressed as a result of exposure to cigarette smoke. The ontologies for these genes are shown in Table V . CYP1B1 is a well known phase-1 biotransformation enzyme involved in the metabolism of carcinogens. Our data confirm previous studies, where increased CYP1B1 mRNA levels have already been found in smokers and lung cancer patients (21) (22) (23) . Whether expression changes for this gene reflect exposure rather than genotoxic effect is not clear from the current data. SOD2 is known to be involved in (response to) oxidative stress and superoxide metabolism, scavenging intracellular oxidants, thus functioning as a defense mechanism. SOD2 has been found to be triggered by smoking as it has been found elevated in the lungs of smokers (25) . MAPK14 has not directly been linked to exposure to cigarette smoke, but more generally to environmental exposures and stress conditions (26, 27) . MAPK14 signaling is suggested to play a crucial role in the regulation of cellular proliferation and differentiation and recent studies suggest a (main) role in protecting cells from apoptosis (28, 29) . Therefore, this gene might be hypothesized to mark an effect rather than an exposure. ATF4 activation has been reported in HepG2 cells after arsenite exposure (30) , but no data are available for primary (human) cells or tissues from exposed populations. For SERPINB2, a role has been suggested in (malignancy of) endometrial cancer (31) and this gene is expressed in many tumors (32) . The gene has also shown to confer resistance to apoptosis (33) . Members of the SERPIN gene family of serine protease inhibitors has also been reported to be involved in COPD, emphysema and associated with lung cancer risk (34) (35) (36) . Induction of differential gene expression of these five genes by cigarette smoking could therefore be the subject of further investigation in larger populations.
Our second approach was to identify genes for which the expression is associated with an established biomarker for early effect, like DNA adducts (see Table III ). Although DNA adduct levels significantly differed between smokers and non-smokers (P-value ¼ 0.04), a clear overlap existed between both groups. Therefore, gene expressions associated with DNA adduct levels, not necessarily have to discriminate smokers from non-smokers. Indeed, none of the genes differentially expressed between smokers and non-smokers were in the list of genes correlating with DNA adducts. Another explanation for lack of overlap between both gene lists might be that cigarette smoke is composed of much more carcinogens and chemicals than those that cause DNA adducts as measurable by 32 P-postlabeling. The adduct levels found in the study population are well within range of values found in other studies (37) . Unfortunately, when verifying the expression of the correlating genes by real-time PCR and correlating these expression data with DNA adducts no significances were found. Possibly this can be attributed to the small expression range of these genes, which in general is much smaller than that for the genes differentially expressed between smokers and non-smokers. This finding suggests lower specificity of DNA adducts as compared to differential gene expression for the measurement of effects of cigarette smoke exposure.
The genes we found to be differentially expressed in peripheral blood from cigarette smokers compared with nonsmokers within monozygotic twin pairs, have not been reported by other similar studies in which differential gene expression has been measured in vivo in peripheral blood (9) (10) (11) . In a study in leukocytes by Lampe et al. (10) differential gene expression in smokers and non-smokers was investigated and genes have been reported that correlated significantly with plasma cotinine levels. For comparison with this study, we investigated the correlation of CYP1B1 and IL-1b (the only two genes reported by Lampe et al. that were also present on our microarrays) between the individual gene expression and individual cotinine levels. We did not find significant correlations of these genes with plasma cotinine levels in our data (Spearman test, P > 0.05). Reasons for this might be that Lampe et al. used a different platform and approach for selecting gene expressions and that they investigated a study population with a larger variation in subjects' age. Another recent study has investigated differential gene expression in blood from individuals exposed to metal fumes (11) . Upon analyzing the subgroup of smokers in that study, it was suggested that cigarette smoking considerably affected whole-blood gene expression profiles. It was also proven that, with a paired-samples study design, it was possible to measure small changes in gene expression in a population study, which is in line with our findings. However, also Wang et al. used another platform and did not verify their main findings with an independent technique like real-time PCR. A study in benzene-exposed factory workers reported to have found a set of genes as potential biomarkers of benzene exposure (12) . Although benzene is a component of cigarette smoke, it does not appear that after exposure to cigarette smoke benzene is an important component to alter gene expression, as no genes were reported that resemble the data of the present study. Again this study used another platform and a smaller study population.
Besides the above mentioned human studies, research on cigarette smoke-induced gene expression changes in animal models has been reported. In SKH-1 mice, cigarette smoke exposure induces MAPK expression (38, 39) , and expression of a SERPIN (trypsin-chemotrypsin-related serine protease) gene (38) . In fetal liver of Swiss albino mice, exposure to environmental cigarette smoke induced expression of CYP genes as well as precursors for two SODs (39) . Several MAPKs have been shown to be upregulated by cigarette smoke in the lungs of A/J mice (40) .
When performing real-time PCR analyses of gene expression, the data can be normalized by either using the same amount of input RNA or by including housekeeping or stably expressed genes in the analyses (16) . When verifying our microarray data by real-time PCR for the differentially expressed genes, consistency between both methods depended on the approach to normalize the real-time PCR data. The best reproducibility of the microarray data was achieved by the DC t method (see Table IV ), where the amount of input RNA was used for normalization, instead of one or more housekeeping genes.
The present study is one of the few studies that apply transcriptomics within the field of molecular epidemiology. Because of the limited history, the application of toxicogenomic tools in molecular epidemiology may be influenced by some limitations and pitfalls. For example, in toxicogenomic research microarrays are most often used in qualitative manner; to get an overview of expression changes of large numbers of genes. It is common practice to verify (the most relevant) findings of microarray experiments with real-time PCR, which represents a more quantitative assay (9, 12, 24) . As is discussed above, the results of both techniques can deviate. In relation to this, is the issue of (choosing the right) 'housekeeping' gene(s) to be included in the real-time PCR analyses for normalization. Another pitfall or limitation of microarray methodologies can be the issue of multicomparison testing, which is prone to deliver false-positive results (12, 41) . This potential problem was dealt with in the current study by performing different statistical analyses and regarding as the most interesting set of genes, only those that showed significant results in all of the tests. Further developments in the field of toxicogenomics and transcriptomics, the technologies and data analyses, will provide ways to handle these limitations and pitfalls in the future.
Summarizing, this study on cigarette smoking-induced differential gene expression in peripheral blood from monozygotic smoking-discordant twins showed that gene expression analysis of many genes simultaneously yields a gene expression profile as promising biomarker of effect induced by cigarette smoking. Five genes were revealed that we would propose to be suitable for biomonitoring in a human population, namely SOD2, MAPK14, ATF4, CYP1B1 and SERPINB2.
